ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.41
1.26%
US Tech 100
19,634.00
0.79%
S&P 500
5,537.02
0.51%
US Dollar vs CAD
1.36405
-0.27%
Bitcoin
60,183.09
-2.97%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. XOMA Corporation (XOMAP)

  7. XOMA Corporation (XOMAP) News

XOMAP

XOMA (XOMAP)

XOMA Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XOMAP
DateTimeSourceHeadlineSymbolCompany
06/20/20246:30AMGlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAPXOMA Corporation
06/17/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XOMAPXOMA Corporation
06/17/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XOMAPXOMA Corporation
06/13/20243:31PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:XOMAPXOMA Corporation
06/12/20246:30AMGlobeNewswire Inc.XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review VoucherNASDAQ:XOMAPXOMA Corporation
05/30/20243:43PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
05/17/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
05/17/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
05/17/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
05/17/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
05/17/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
05/17/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XOMAPXOMA Corporation
05/16/20246:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
05/14/20246:30AMGlobeNewswire Inc.XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQNASDAQ:XOMAPXOMA Corporation
05/09/20246:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
05/09/20246:35AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XOMAPXOMA Corporation
05/09/20246:30AMGlobeNewswire Inc.XOMA Reports First Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAPXOMA Corporation
04/30/20246:30AMGlobeNewswire Inc.XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%NASDAQ:XOMAPXOMA Corporation
04/25/20246:30AMGlobeNewswire Inc.XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)NASDAQ:XOMAPXOMA Corporation
04/03/20248:00AMGlobeNewswire Inc.XOMA Corporation Announces Closing of Tender OfferNASDAQ:XOMAPXOMA Corporation
03/21/20246:30AMGlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAPXOMA Corporation
03/19/20243:05PMGlobeNewswire Inc.XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.NASDAQ:XOMAPXOMA Corporation
03/11/20245:56AMEdgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:XOMAPXOMA Corporation
03/08/20243:34PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:XOMAPXOMA Corporation
03/08/20246:39AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
03/08/20246:30AMGlobeNewswire Inc.XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder ValueNASDAQ:XOMAPXOMA Corporation
03/04/20244:24PMEdgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:XOMAPXOMA Corporation
02/28/20246:30AMGlobeNewswire Inc.XOMA to Present at Upcoming Investor Conferences in MarchNASDAQ:XOMAPXOMA Corporation
02/16/20248:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XOMAPXOMA Corporation
02/16/20247:00AMGlobeNewswire Inc.XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value RightNASDAQ:XOMAPXOMA Corporation
 Showing the most relevant articles for your search:NASDAQ:XOMAP

Your Recent History

NASDAQ
TSLA
Tesla
AMEX
OPTT
Ocean Power Technologies
USOTC
KEGS
1812 Brewing (PK)
USOTC
NNAX
New Momentum (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
MGON
Megola (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
FCEL
FuelCell Energy
USOTC
ASKH
Astika (PK)
USOTC
MVNT
Movement Industries (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
AXXA
Exxe (PK)
USOTC
SPZI
Spooz (PK)
USOTC
ENZC
Enzolytics (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved